Click for best price
Radioimmunotherapy Market Size, Share 2022
This report contains market size and forecasts of Radioimmunotherapy in Global, including the following market information:
Global Radioimmunotherapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Radioimmunotherapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Non Hodgkin Lymphoma (NHL) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Radioimmunotherapy include Bayer Healthcare Pharmaceuticals, BioSynthema, Clarity Pharmaceuticals, Curasight, Endocyte, Immunomedics, Molecular Insight Pharmaceuticals, Nordic Nanovector and PDL Biopharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Radioimmunotherapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Radioimmunotherapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Radioimmunotherapy Market Segment Percentages, by Type, 2021 (%)
Non Hodgkin Lymphoma (NHL)
Follicular Lymphoma
Solid Tumors
Breast Cancer
Ovarian Cancer
Osteosarcoma
Neuroblastoma
Prostate Cancer
Global Radioimmunotherapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Radioimmunotherapy Market Segment Percentages, by Application, 2021 (%)
Tumor Antigens
Radionuclides
Antibodies
Global Radioimmunotherapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Radioimmunotherapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Radioimmunotherapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Radioimmunotherapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer Healthcare Pharmaceuticals
BioSynthema
Clarity Pharmaceuticals
Curasight
Endocyte
Immunomedics
Molecular Insight Pharmaceuticals
Nordic Nanovector
PDL Biopharma
Philogen
RadioMedix
Stella Pharma
Telix Pharmaceuticals
| Report Attributes |
Report Details |
| Report Title |
Radioimmunotherapy Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
63 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Radioimmunotherapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Radioimmunotherapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Radioimmunotherapy Overall Market Size
2.1 Global Radioimmunotherapy Market Size: 2021 VS 2028
2.2 Global Radioimmunotherapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Radioimmunotherapy Players in Global Market
3.2 Top Global Radioimmunotherapy Companies Ranked by Revenue
3.3 Global Radioimmunotherapy Revenue by Companies
3.4 Top 3 and Top 5 Radioimmunotherapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Radioimmunotherapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Radioimmunotherapy Players in Global Market
3.6.1 List of Global Tier 1 Radioimmunotherapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Radioimmunotherapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Radioimmunotherapy Market Size Markets, 2021 & 2028
4.1.2 Non Hodgkin Lymphoma (NHL)
4.1.3 Follicular Lymphoma
4.1.4 Solid Tumors
4.1.5 Breast Cancer
4.1.6 Ovarian Cancer
4.1.7 Osteosarcoma
4.1.8 Neuroblastoma
4.1.9 Prostate Cancer
4.2 By Type - Global Radioimmunotherapy Revenue & Forecasts
4.2.1 By Type - Global Radioimmunotherapy Revenue, 2017-2022
4.2.2 By Type - Global Radioimmunotherapy Revenue, 2023-2028
4.2.3 By Type - Global Radioimmunotherapy Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Radioimmunotherapy Market Size, 2021 & 2028
5.1.2 Tumor Antigens
5.1.3 Radionuclides
5.1.4 Antibodies
5.2 By Application - Global Radioimmunotherapy Revenue & Forecasts
5.2.1 By Application - Global Radioimmunotherapy Revenue, 2017-2022
5.2.2 By Application - Global Radioimmunotherapy Revenue, 2023-2028
5.2.3 By Application - Global Radioimmunotherapy Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Radioimmunotherapy Market Size, 2021 & 2028
6.2 By Region - Global Radioimmunotherapy Revenue & Forecasts
6.2.1 By Region - Global Radioimmunotherapy Revenue, 2017-2022
6.2.2 By Region - Global Radioimmunotherapy Revenue, 2023-2028
6.2.3 By Region - Global Radioimmunotherapy Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Radioimmunotherapy Revenue, 2017-2028
6.3.2 US Radioimmunotherapy Market Size, 2017-2028
6.3.3 Canada Radioimmunotherapy Market Size, 2017-2028
6.3.4 Mexico Radioimmunotherapy Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Radioimmunotherapy Revenue, 2017-2028
6.4.2 Germany Radioimmunotherapy Market Size, 2017-2028
6.4.3 France Radioimmunotherapy Market Size, 2017-2028
6.4.4 U.K. Radioimmunotherapy Market Size, 2017-2028
6.4.5 Italy Radioimmunotherapy Market Size, 2017-2028
6.4.6 Russia Radioimmunotherapy Market Size, 2017-2028
6.4.7 Nordic Countries Radioimmunotherapy Market Size, 2017-2028
6.4.8 Benelux Radioimmunotherapy Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Radioimmunotherapy Revenue, 2017-2028
6.5.2 China Radioimmunotherapy Market Size, 2017-2028
6.5.3 Japan Radioimmunotherapy Market Size, 2017-2028
6.5.4 South Korea Radioimmunotherapy Market Size, 2017-2028
6.5.5 Southeast Asia Radioimmunotherapy Market Size, 2017-2028
6.5.6 India Radioimmunotherapy Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Radioimmunotherapy Revenue, 2017-2028
6.6.2 Brazil Radioimmunotherapy Market Size, 2017-2028
6.6.3 Argentina Radioimmunotherapy Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Radioimmunotherapy Revenue, 2017-2028
6.7.2 Turkey Radioimmunotherapy Market Size, 2017-2028
6.7.3 Israel Radioimmunotherapy Market Size, 2017-2028
6.7.4 Saudi Arabia Radioimmunotherapy Market Size, 2017-2028
6.7.5 UAE Radioimmunotherapy Market Size, 2017-2028
7 Players Profiles
7.1 Bayer Healthcare Pharmaceuticals
7.1.1 Bayer Healthcare Pharmaceuticals Corporate Summary
7.1.2 Bayer Healthcare Pharmaceuticals Business Overview
7.1.3 Bayer Healthcare Pharmaceuticals Radioimmunotherapy Major Product Offerings
7.1.4 Bayer Healthcare Pharmaceuticals Radioimmunotherapy Revenue in Global Market (2017-2022)
7.1.5 Bayer Healthcare Pharmaceuticals Key News
7.2 BioSynthema
7.2.1 BioSynthema Corporate Summary
7.2.2 BioSynthema Business Overview
7.2.3 BioSynthema Radioimmunotherapy Major Product Offerings
7.2.4 BioSynthema Radioimmunotherapy Revenue in Global Market (2017-2022)
7.2.5 BioSynthema Key News
7.3 Clarity Pharmaceuticals
7.3.1 Clarity Pharmaceuticals Corporate Summary
7.3.2 Clarity Pharmaceuticals Business Overview
7.3.3 Clarity Pharmaceuticals Radioimmunotherapy Major Product Offerings
7.3.4 Clarity Pharmaceuticals Radioimmunotherapy Revenue in Global Market (2017-2022)
7.3.5 Clarity Pharmaceuticals Key News
7.4 Curasight
7.4.1 Curasight Corporate Summary
7.4.2 Curasight Business Overview
7.4.3 Curasight Radioimmunotherapy Major Product Offerings
7.4.4 Curasight Radioimmunotherapy Revenue in Global Market (2017-2022)
7.4.5 Curasight Key News
7.5 Endocyte
7.5.1 Endocyte Corporate Summary
7.5.2 Endocyte Business Overview
7.5.3 Endocyte Radioimmunotherapy Major Product Offerings
7.5.4 Endocyte Radioimmunotherapy Revenue in Global Market (2017-2022)
7.5.5 Endocyte Key News
7.6 Immunomedics
7.6.1 Immunomedics Corporate Summary
7.6.2 Immunomedics Business Overview
7.6.3 Immunomedics Radioimmunotherapy Major Product Offerings
7.6.4 Immunomedics Radioimmunotherapy Revenue in Global Market (2017-2022)
7.6.5 Immunomedics Key News
7.7 Molecular Insight Pharmaceuticals
7.7.1 Molecular Insight Pharmaceuticals Corporate Summary
7.7.2 Molecular Insight Pharmaceuticals Business Overview
7.7.3 Molecular Insight Pharmaceuticals Radioimmunotherapy Major Product Offerings
7.7.4 Molecular Insight Pharmaceuticals Radioimmunotherapy Revenue in Global Market (2017-2022)
7.7.5 Molecular Insight Pharmaceuticals Key News
7.8 Nordic Nanovector
7.8.1 Nordic Nanovector Corporate Summary
7.8.2 Nordic Nanovector Business Overview
7.8.3 Nordic Nanovector Radioimmunotherapy Major Product Offerings
7.8.4 Nordic Nanovector Radioimmunotherapy Revenue in Global Market (2017-2022)
7.8.5 Nordic Nanovector Key News
7.9 PDL Biopharma
7.9.1 PDL Biopharma Corporate Summary
7.9.2 PDL Biopharma Business Overview
7.9.3 PDL Biopharma Radioimmunotherapy Major Product Offerings
7.9.4 PDL Biopharma Radioimmunotherapy Revenue in Global Market (2017-2022)
7.9.5 PDL Biopharma Key News
7.10 Philogen
7.10.1 Philogen Corporate Summary
7.10.2 Philogen Business Overview
7.10.3 Philogen Radioimmunotherapy Major Product Offerings
7.10.4 Philogen Radioimmunotherapy Revenue in Global Market (2017-2022)
7.10.5 Philogen Key News
7.11 RadioMedix
7.11.1 RadioMedix Corporate Summary
7.11.2 RadioMedix Business Overview
7.11.3 RadioMedix Radioimmunotherapy Major Product Offerings
7.11.4 RadioMedix Radioimmunotherapy Revenue in Global Market (2017-2022)
7.11.5 RadioMedix Key News
7.12 Stella Pharma
7.12.1 Stella Pharma Corporate Summary
7.12.2 Stella Pharma Business Overview
7.12.3 Stella Pharma Radioimmunotherapy Major Product Offerings
7.12.4 Stella Pharma Radioimmunotherapy Revenue in Global Market (2017-2022)
7.12.5 Stella Pharma Key News
7.13 Telix Pharmaceuticals
7.13.1 Telix Pharmaceuticals Corporate Summary
7.13.2 Telix Pharmaceuticals Business Overview
7.13.3 Telix Pharmaceuticals Radioimmunotherapy Major Product Offerings
7.13.4 Telix Pharmaceuticals Radioimmunotherapy Revenue in Global Market (2017-2022)
7.13.5 Telix Pharmaceuticals Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Radioimmunotherapy Market Opportunities & Trends in Global Market
Table 2. Radioimmunotherapy Market Drivers in Global Market
Table 3. Radioimmunotherapy Market Restraints in Global Market
Table 4. Key Players of Radioimmunotherapy in Global Market
Table 5. Top Radioimmunotherapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Radioimmunotherapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Radioimmunotherapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Radioimmunotherapy Product Type
Table 9. List of Global Tier 1 Radioimmunotherapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Radioimmunotherapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Radioimmunotherapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Radioimmunotherapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Radioimmunotherapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Radioimmunotherapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Radioimmunotherapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Radioimmunotherapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Radioimmunotherapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Radioimmunotherapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Radioimmunotherapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Radioimmunotherapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Radioimmunotherapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Radioimmunotherapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Radioimmunotherapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Radioimmunotherapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Radioimmunotherapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Radioimmunotherapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Radioimmunotherapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Radioimmunotherapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Radioimmunotherapy Revenue, (US$, Mn), 2023-2028
Table 30. Bayer Healthcare Pharmaceuticals Corporate Summary
Table 31. Bayer Healthcare Pharmaceuticals Radioimmunotherapy Product Offerings
Table 32. Bayer Healthcare Pharmaceuticals Radioimmunotherapy Revenue (US$, Mn), (2017-2022)
Table 33. BioSynthema Corporate Summary
Table 34. BioSynthema Radioimmunotherapy Product Offerings
Table 35. BioSynthema Radioimmunotherapy Revenue (US$, Mn), (2017-2022)
Table 36. Clarity Pharmaceuticals Corporate Summary
Table 37. Clarity Pharmaceuticals Radioimmunotherapy Product Offerings
Table 38. Clarity Pharmaceuticals Radioimmunotherapy Revenue (US$, Mn), (2017-2022)
Table 39. Curasight Corporate Summary
Table 40. Curasight Radioimmunotherapy Product Offerings
Table 41. Curasight Radioimmunotherapy Revenue (US$, Mn), (2017-2022)
Table 42. Endocyte Corporate Summary
Table 43. Endocyte Radioimmunotherapy Product Offerings
Table 44. Endocyte Radioimmunotherapy Revenue (US$, Mn), (2017-2022)
Table 45. Immunomedics Corporate Summary
Table 46. Immunomedics Radioimmunotherapy Product Offerings
Table 47. Immunomedics Radioimmunotherapy Revenue (US$, Mn), (2017-2022)
Table 48. Molecular Insight Pharmaceuticals Corporate Summary
Table 49. Molecular Insight Pharmaceuticals Radioimmunotherapy Product Offerings
Table 50. Molecular Insight Pharmaceuticals Radioimmunotherapy Revenue (US$, Mn), (2017-2022)
Table 51. Nordic Nanovector Corporate Summary
Table 52. Nordic Nanovector Radioimmunotherapy Product Offerings
Table 53. Nordic Nanovector Radioimmunotherapy Revenue (US$, Mn), (2017-2022)
Table 54. PDL Biopharma Corporate Summary
Table 55. PDL Biopharma Radioimmunotherapy Product Offerings
Table 56. PDL Biopharma Radioimmunotherapy Revenue (US$, Mn), (2017-2022)
Table 57. Philogen Corporate Summary
Table 58. Philogen Radioimmunotherapy Product Offerings
Table 59. Philogen Radioimmunotherapy Revenue (US$, Mn), (2017-2022)
Table 60. RadioMedix Corporate Summary
Table 61. RadioMedix Radioimmunotherapy Product Offerings
Table 62. RadioMedix Radioimmunotherapy Revenue (US$, Mn), (2017-2022)
Table 63. Stella Pharma Corporate Summary
Table 64. Stella Pharma Radioimmunotherapy Product Offerings
Table 65. Stella Pharma Radioimmunotherapy Revenue (US$, Mn), (2017-2022)
Table 66. Telix Pharmaceuticals Corporate Summary
Table 67. Telix Pharmaceuticals Radioimmunotherapy Product Offerings
Table 68. Telix Pharmaceuticals Radioimmunotherapy Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Radioimmunotherapy Segment by Type in 2021
Figure 2. Radioimmunotherapy Segment by Application in 2021
Figure 3. Global Radioimmunotherapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Radioimmunotherapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Radioimmunotherapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Radioimmunotherapy Revenue in 2021
Figure 8. By Type - Global Radioimmunotherapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Radioimmunotherapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Radioimmunotherapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Radioimmunotherapy Revenue Market Share, 2017-2028
Figure 12. US Radioimmunotherapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Radioimmunotherapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Radioimmunotherapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Radioimmunotherapy Revenue Market Share, 2017-2028
Figure 16. Germany Radioimmunotherapy Revenue, (US$, Mn), 2017-2028
Figure 17. France Radioimmunotherapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Radioimmunotherapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Radioimmunotherapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Radioimmunotherapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Radioimmunotherapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Radioimmunotherapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Radioimmunotherapy Revenue Market Share, 2017-2028
Figure 24. China Radioimmunotherapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Radioimmunotherapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Radioimmunotherapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Radioimmunotherapy Revenue, (US$, Mn), 2017-2028
Figure 28. India Radioimmunotherapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Radioimmunotherapy Revenue Market Share, 2017-2028
Figure 30. Brazil Radioimmunotherapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Radioimmunotherapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Radioimmunotherapy Revenue Market Share, 2017-2028
Figure 33. Turkey Radioimmunotherapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Radioimmunotherapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Radioimmunotherapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Radioimmunotherapy Revenue, (US$, Mn), 2017-2028
Figure 37. Bayer Healthcare Pharmaceuticals Radioimmunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. BioSynthema Radioimmunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Clarity Pharmaceuticals Radioimmunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Curasight Radioimmunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Endocyte Radioimmunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Immunomedics Radioimmunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Molecular Insight Pharmaceuticals Radioimmunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Nordic Nanovector Radioimmunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. PDL Biopharma Radioimmunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Philogen Radioimmunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. RadioMedix Radioimmunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Stella Pharma Radioimmunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Telix Pharmaceuticals Radioimmunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
